We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...

Precision Biosciences' ARCUS platform offers high precision and versatility, supporting in vivo gene editing therapies, and ...

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi ...